Kinome-wide siRNA screen identifies a DCLK2-TBK1 oncogenic signaling axis in clear cell renal cell carcinoma-Reference-Cited by-同舟云学术

Kinome-wide siRNA screen identifies a DCLK2-TBK1 oncogenic signaling axis in clear cell renal cell carcinoma

Published:2024-02 Issue:4 Volume:84 Page:776-790.e5
ISSN:1097-2765
Container-title:Molecular Cell
language:en
Short-container-title:Molecular Cell

Author:

Hu Lianxin,Zhang Yanfeng,Guo Lei,Zhong Hua,Xie Ling,Zhou Jin,Liao Chengheng,Yao Hongwei,Fang Jun,Liu Hongyi,Zhang Cheng,Zhang Hui,Zhu Xiaoqiang,Luo Maowu,von Kriegsheim Alex,Li Bufan,Luo Weibo,Zhang Xuewu,Chen Xian,Mendell Joshua T.,Xu Lin,Kapur Payal,Baldwin Albert S.,Brugarolas James,Zhang Qing^ORCID

Funder

National Institutes of Health

National Cancer Institute

Cancer Prevention and Research Institute of Texas

Publisher

Elsevier BV

Reference67 articles.

1. Molecular basis of the VHL hereditary cancer syndrome;Kaelin;Nat. Rev. Cancer,2002

2. The VHL tumor suppressor in development and disease: functional studies in mice by conditional gene targeting;Haase;Semin. Cell Dev. Biol.,2005

3. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation;Jaakkola;Science,2001

4. HIFα targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing;Ivan;Science,2001

5. Genetic and functional studies implicate HIF1alpha as a 14q kidney cancer suppressor gene;Shen;Cancer Discov.,2011

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanism of TBK1 activation in cancer cells;Cell Insight;2024-10

2. VHL synthetic lethality screens uncover CBF-β as a negative regulator of STING;2024-09-06

3. The role of BUD31 in clear cell renal cell carcinoma: prognostic significance, alternative splicing, and tumor immune environment;Clinical and Experimental Medicine;2024-08-13

4. A way to block TBK1 in ccRCC;Science Signaling;2024-02-27